Featured Research

from universities, journals, and other organizations

Genetically diverse cancer cells key to brain tumor resistance

Date:
January 30, 2014
Source:
Virginia Tech
Summary:
For a cancer cell, it pays to have a group of eccentric friends. Like X-Men characters, a group of cancer cells with diverse physical traits is safer, because it takes different strategies to kill each member. The more diverse the group, the better the chances are for individual cells to survive and join forces as a cohesive tumor.

In this image of mouse brain tissue containing human brain tumor cells, red dye shows invasive, stem-like cells that carry two copies of chromosome 7, while green dye depicts non-stem-like cells that carry three copies of the problematic chromosome. The cells can change into one another by adding or deleting copies of of chromosome 7. Mathematical modeling suggested the involvement of chromosome instability helps tumor cells fend off treatment.
Credit: Yi-Hong Zhou/University of California-Irvine

For a cancer cell, it pays to have a group of eccentric friends.

Like X-Men characters, a group of cancer cells with diverse physical traits is safer, because it takes different strategies to kill each member.

The more diverse the group, the better the chances are for individual cells to survive and join forces as a cohesive tumor.

A multi-university research team, including researchers with the Fralin Life Science Institute at Virginia Tech, discovered that the unique physical differences among brain tumor cells were because of chromosomal abnormalities.

Understanding the biology behind diverse cell production in cancerous brain tumors may contribute to knowledge for better treatments, according to Jianhua Xing, an associate professor of biological sciences in the College of Science and a Fralin Life Science Institute affiliate.

Xing, with Yi-Hong Zhou, an assistant professor of neurological surgery in the School of Medicine at the University of California-Irvine, concluded that tumor cells with genes that have varying numbers of copies of chromosome 7 leads to cell diversity and survival of brain tumors.

Cancer cells bypass the surveillance systems that limit the number of copies of chromosomes in normal cells to produce an abnormal number of chromosomes.

Zhou, whose research program is devoted to developing novel drugs to treat brain cancer, led the experimental portion of the project, and Xing, an expert in mathematical modeling of biological systems, analyzed the results.

The discovery was published in November in PLOS One.

"Cancer is a biological entity that continues to evolve, where the cancer ecosystem, with its dynamic interactions among cancer cells and normal cells, selects the best cells to survive," Zhou said. "Our findings presented only one aspect, among many others, that cancer cells use to change, with mis-segregation of chromosomes clearly being the most powerful one. By applying this concept of cancer survivability, a rewarding therapeutic approach might be developed through reducing random or chance development of tumor cells, which we are currently investigating."

The project involved 21 members from the University of California-Irvine, Virginia Tech, the Veterans Affairs Medical Center at Long Beach, the University of Arkansas for Medical Sciences academic health center, Ziren Research LLC, and the National Engineering Center for Biochip at Shanghai in China.

Key work was done by Yuanjie Hu, a graduate student at the University of California-Irvine; Hang Zhang of Hebei, China, a graduate student at Virginia Tech; Xiao-Jun Tian, a postdoctoral associate at Virginia Tech; and two research specialists -- Ning Ru of the University of California-Irvine and Neil T. Hoa of the Veterans Affairs Medical Center at Long Beach.

"While it's unlikely that this finding is the only mechanism that controls cancer plasticity, it is a piece of the puzzle," said Xing. "Cancer cells are, unfortunately, very smart. That is why the battle against cancer is so difficult."


Story Source:

The above story is based on materials provided by Virginia Tech. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yuanjie Hu, Ning Ru, Huasheng Xiao, Abhishek Chaturbedi, Neil T. Hoa, Xiao-Jun Tian, Hang Zhang, Chao Ke, Fengrong Yan, Jodi Nelson, Zhenzhi Li, Robert Gramer, Liping Yu, Eric Siegel, Xiaona Zhang, Zhenyu Jia, Martin R. Jadus, Charles L. Limoli, Mark E. Linskey, Jianhua Xing, Yi-Hong Zhou. Tumor-Specific Chromosome Mis-Segregation Controls Cancer Plasticity by Maintaining Tumor Heterogeneity. PLoS ONE, 2013; 8 (11): e80898 DOI: 10.1371/journal.pone.0080898

Cite This Page:

Virginia Tech. "Genetically diverse cancer cells key to brain tumor resistance." ScienceDaily. ScienceDaily, 30 January 2014. <www.sciencedaily.com/releases/2014/01/140130155827.htm>.
Virginia Tech. (2014, January 30). Genetically diverse cancer cells key to brain tumor resistance. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/01/140130155827.htm
Virginia Tech. "Genetically diverse cancer cells key to brain tumor resistance." ScienceDaily. www.sciencedaily.com/releases/2014/01/140130155827.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins